UV Sensor in Patients With Actinic Keratosis
Pilot Feasibility Study of Using UV Sensor in Patients With Actinic Keratosis
1 other identifier
observational
10
1 country
1
Brief Summary
To validate the use of Ultraviolet (UV) radiation sensor in patients with actinic keratosis, to identify barriers to its use in prospective longitudinal studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2022
CompletedFirst Submitted
Initial submission to the registry
June 22, 2022
CompletedFirst Posted
Study publicly available on registry
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedNovember 14, 2022
November 1, 2022
2 months
June 22, 2022
November 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
QOL UV sensor
Questionnaire will be carried out to qualitatively evaluate different aspects of the usability of the UV device, Minimum Value 0; Maximun Value 20, where higher value is the better.
Up to week 4
Interventions
Use of UV sensor to be informed about the sun exposure daily through a mobile application
Eligibility Criteria
Non-hospitalized patients routinely seen in dermatology outpatient clinics who meet the inclusion criteria will be offered the possibility of participating in the study.
You may qualify if:
- \>=65 years presenting actinic keratosis on scalp and/or face
You may not qualify if:
- Patients who, due to health problems or lifestyle habits, do not expose themselves regularly to UV radiation (outdoor) for at least one hour a day.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Almirall, S.A.lead
Study Sites (1)
Dermatology Unit (Hospital Clinic)
Barcelona, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2022
First Posted
August 1, 2022
Study Start
June 13, 2022
Primary Completion
August 2, 2022
Study Completion
September 1, 2022
Last Updated
November 14, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share